GenSci Launches Global Innovation Hub in Shanghai
The Establishment of the Facility Demonstrates the Company's Commitment to Delivering Differentiated Solutions to Gynecology and Pediatrics Challenges SHANGHAI, Dec. 22, 2023 /PRNewswire/ -- Changchun GeneScience Pharmaceutical ("GenSci"), a subsidiary of Changchun High-Tech Industries (Group), held a groundbreaking ceremony for its new global headquarters and research & development (R&D) center at Shanghai Zhangjiang International Medical Park on December...
Fortified Health Security Recognized with Frost & Sullivan’s 2024 North American Customer Value Leadership Award for Delivering Unmatched Cybersecurity Protection in Healthcare
Fortified Health Security's customer-driven approach and state-of-the-art cybersecurity services help healthcare providers combat cyber threats while optimizing security operations for its customers. SAN ANTONIO, March 13, 2025 /PRNewswire/ -- Frost & Sullivan recently researched the North American healthcare cybersecurity industry and, based on its findings, recognizes Fortified Health Security with the 2024 North American Customer Value Leadership Award. Fortified Health Security is a...
R&D Progress: Enrollment of Subjects in Phase III Clinical Trial for Inhaled Aerosol Drug in Children by Kexing Biopharm
SHENZHEN, China, April 10, 2024 /PRNewswire/ -- Recently, Kexing Biopharm (688136.SH) announced that the Phase III clinical trial of Human Interferon α1b Inhalation Solution developed by its wholly-owned subsidiary, Shenzhen Kexing Pharmaceutical Co., Ltd., had completed the enrollment of first patient and dosing. This drug is indicated for respiratory syncytial virus-associated lower respiratory infections (pneumonia, bronchiolitis) in children. It...
Norma Completes Quantum AI Algorithm Validation on NVIDIA
"Quantum AI up to 73x Faster on NVIDIA CUDA-Q" Norma, a quantum computing company, has validated the performance of quantum AI algorithms using NVIDIA CUDA-Q. By running these algorithms for drug development on CUDA-Q, Norma observed computational speeds up to 73 times faster. The company has secured use cases for quantum AI in drug development and plans to...
World’s Leading Neuroscientists Unveil Research on COVID-19’s Impact on the Brain, Understanding Migraine Pathophysiology, Solving the Mystery of Sleep, Biomarkers in Traumatic Brain Injury and More at 25th Biennial...
LONDON, Oct. 2, 2021 /PRNewswire/ -- The impact COVID-19 has on the brain, understanding migraine pathophysiology, solving the mystery of sleep by "Lighting Up the Brain," blood biomarkers for traumatic brain injury and more groundbreaking research will be unveiled by the world's leading neuroscientists at the 25th Biennial World Congress of Neurology (WCN) on October 3 through 7, 2021, presented...
USANA Named No. 1 Vitamins and Dietary Supplements Brand in Philippines
Euromonitor honors USANA Philippines for fifth time MANILA, Philippines, Jan. 3, 2024 /PRNewswire/ -- USANA Health Sciences, Inc., a leader in the health and wellness industry, was named the number one vitamin and dietary supplement brand in Philippines* by Euromonitor. This marks the fifth time USANA Philippines has received this honor. To discover USANA's line...
Anti-HER2 Bispecific ADC JSKN003 Received Approval to Initiate a Phase III Clinical Study for the Treatment of HER2-positive Breast Cancer
SUZHOU, China, Feb. 6, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) to initiate a Phase III clinical study (Study ID: JSKN003-301). The...
LTS takes next step in its Growth Journey with the acquisition of Tapemark Inc.
ANDERNACH, Germany, Aug. 22, 2022 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS") announces the closing of the acquisition of Tapemark Inc. ("Tapemark") located in St. Paul, MN, USA. This acquisition combines Tapemark, a world-class CDMO specialized in transdermal drug delivery systems and oral thin films as well as unit dose semi-solid drug and iontophoresis products with LTS, a leading...
Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer
Daly, a 30-year veteran of the healthcare industry, is the latest leadership addition to help Terumo BCT unite business areas and fuel enterprise growth LAKEWOOD, Colo., April 17, 2025 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the addition of Patrick Daly as its Chief...
Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy
MELBOURNE, Australia and SAN FRANCISCO, July 6, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the first patient has been dosed in the Company's Phase 2 clinical trial of ATH434 in Multiple System Atrophy...
